Products
Companies
News
About
About
Add your product
Contact
Newsletter
×
Subscribe to our monthly newsletter
Subscribe
Products
icobrain ms
icobrain ms
icometrix
icobrain ms helps physicians assess (sub)clinical disease activity in patients with multiple sclerosis.
icobrain ms allows for the objective assessment of lesion dissemination in space and time by:
- Quantifying and tracking FLAIR WM hyperintensities and T1 WM hypointensities
icobrain ms provides measures of brain volume changes by:
- Tracking annualized brain volume changes for whole brain and gray matter
- Comparing brain volumes and volume changes to an age-and gender-matched reference population.
Information source:
Vendor
Last updated:
March 17, 2024
General Information
Technical Specifications
Regulatory
Market
Evidence
General Information
General
Product name
icobrain ms
Company
icometrix
Subspeciality
Neuro
Modality
MR
Disease targeted
Multiple sclerosis
Key-features
White matter abnormality quantification, brain volume change, report generation
Suggested use
During: perception aid (prompting all abnormalities/results/heatmaps), report suggestion
Technical Specifications
Data characteristics
Population
multiple sclerosis patients
Input
For MRI: 3D T1 weighted image and 3D FLAIR
Input format
DICOM
Output
Color-coded segmentation overlays, concise reports with reference statistics, pre-populated radiological reporting template
Output format
DICOM
Technology
Integration
Integration in standard reading environment (PACS), Integration RIS (Radiological Information System), Integration via AI marketplace or distribution platform
Deployment
Cloud-based
Trigger for analysis
Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
> 10 minutes
Regulatory
Certification
CE
Certified, Class IIa
, MDR
FDA
510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)
icobrain mr is intended for automatic labeling, visualization and volumetric quantification of segmentable brain structures from a set of MR images. This software is intended to automate the current manual process of identifying, labeling and quantifying the volume of segmentable brain structures identified on MR images. icobrain mr consists of two distinct image processing pipelines: icobrain mr cross and icobrain mr long. icobrain mr cross is intended to provide volumes from images acquired at a single timepoint. icobrain mr long is intended to provide changes in volumes between two images that were acquired on the same scanner, with the same image acquisition protocol and with same contrast at two different timepoints. The results of icobrain mr cross cannot be compared with the results of icobrain mr long.
Market
Market presence
On market since
2016
Distribution channels
Blackford, GE Edison marketplace, Nuance PIN, Calantic, Myrian
Countries present (clinical, non-research use)
23
Paying clinical customers (institutes)
>100
Research/test users (institutes)
>300
Pricing
Pricing model
Subscription
Based on
Number of analyses
Evidence
Evidence
Peer reviewed papers on performance
Reliable measurements of brain atrophy in individual patients with multiple sclerosis
(read)
Two Time Point MS Lesion Segmentation in Brain MRI: An Expectation-Maximization Framework
(read)
icobrain ms 5.1: Combining unsupervised and supervised approaches for improving the detection of multiple sclerosis lesions
(read)
Non-peer reviewed papers on performance
Other relevant papers
A Novel Digital Care Management Platform to Monitor Clinical and Subclinical Disease Activity in Multiple Sclerosis
(read)